Metabolic Heterogeneity in Human Lung Tumors

Cell

Volumn 164, Issue 4, 2016, Pages 681-694

  Hensley, Christopher T ^a   Faubert, Brandon ^a   Yuan, Qing ^a   Lev Cohain, Naama ^c   Jin, Eunsook ^a   Kim, Jiyeon ^a   Jiang, Lei ^a   Ko, Bookyung ^a   Skelton, Rachael ^a   Loudat, Laurin ^a   Wodzak, Michelle ^d   Klimko, Claire ^a   McMillan, Elizabeth ^a   Butt, Yasmeen ^a   Ni, Min ^a   Oliver, Dwight ^a   Torrealba, Jose ^a   Malloy, Craig R ^a   Kernstine, Kemp ^a   Lenkinski, Robert E ^a   DeBerardinis, Ralph J ^a,b   more..

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE; GLUCOSE C 13; LACTIC ACID; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON SOURCE; CASE REPORT; CELL METABOLISM; CITRIC ACID CYCLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; DIFFUSION WEIGHTED IMAGING; FEMALE; GENETIC HETEROGENEITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLYCOLYSIS; HUMAN; IN VIVO STUDY; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOGENE K RAS; ONCOLOGICAL PARAMETERS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SUSCEPTIBILITY WEIGHTED IMAGING; TISSUE PERFUSION; TUMOR MICROENVIRONMENT; LUNG TUMOR; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CITRIC ACID CYCLE; FEMALE; GLYCOLYSIS; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TUMOR MICROENVIRONMENT;

EID: 84958120328     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.12.034     Document Type: Article

References (33)

1. L.K. Boroughs, and R.J. DeBerardinis Metabolic pathways promoting cancer cell survival and growth Nat. Cell Biol. 17 2015 351 359
2. J.M. Buescher, M.R. Antoniewicz, L.G. Boros, S.C. Burgess, H. Brunengraber, C.B. Clish, R.J. DeBerardinis, O. Feron, C. Frezza, B. Ghesquiere, and et al. A roadmap for interpreting (13)C metabolite labeling patterns from cells Curr. Opin. Biotechnol. 34 2015 189 201
3. P. Caro, A.U. Kishan, E. Norberg, I.A. Stanley, B. Chapuy, S.B. Ficarro, K. Polak, D. Tondera, J. Gounarides, H. Yin, and et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma Cancer Cell 22 2012 547 560
4. T. Cheng, J. Sudderth, C. Yang, A.R. Mullen, E.S. Jin, J.M. Matés, and R.J. DeBerardinis Pyruvate carboxylase is required for glutamine-independent growth of tumor cells Proc. Natl. Acad. Sci. USA 108 2011 8674 8679
5. S.M. Davidson, T. Papagiannakopoulos, B.A. Olenchock, J.E. Heyman, M.A. Keibler, A. Luengo, M.R. Bauer, A.K. Jha, J.P. O'Brien, K.A. Pierce, and et al. Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer Cell Metab 2016 10.1016/j.cmet.2016.01.007 Published online February 4, 2016
6. R.J. DeBerardinis, J.J. Lum, G. Hatzivassiliou, and C.B. Thompson The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell Metab. 7 2008 11 20
7. M. Eilertsen, S. Andersen, S. Al-Saad, Y. Kiselev, T. Donnem, H. Stenvold, I. Pettersen, K. Al-Shibli, E. Richardsen, L.T. Busund, and R.M. Bremnes Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival PLoS ONE 9 2014 e105038
8. T.W. Fan, A.N. Lane, R.M. Higashi, M.A. Farag, H. Gao, M. Bousamra, and D.M. Miller Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM) Mol. Cancer 8 2009 41
9. J.W. Fletcher, B. Djulbegovic, H.P. Soares, B.A. Siegel, V.J. Lowe, G.H. Lyman, R.E. Coleman, R. Wahl, J.C. Paschold, N. Avril, and et al. Recommendations on the use of 18F-FDG PET in oncology J. Nucl. Med. 49 2008 480 508
10. P. Gao, I. Tchernyshyov, T.-C. Chang, Y.-S. Lee, K. Kita, T. Ochi, K.I. Zeller, A.M. De Marzo, J.E. Van Eyk, J.T. Mendell, and C.V. Dang c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature 458 2009 762 765
11. R.A. Gatenby, and R.J. Gillies Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4 2004 891 899
12. F. Guillaumond, J. Leca, O. Olivares, M.-N. Lavaut, N. Vidal, P. Berthezène, N.J. Dusetti, C. Loncle, E. Calvo, O. Turrini, and et al. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma Proc. Natl. Acad. Sci. USA 110 2013 3919 3924
13. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
14. H. Ji, M.R. Ramsey, D.N. Hayes, C. Fan, K. McNamara, P. Kozlowski, C. Torrice, M.C. Wu, T. Shimamura, S.A. Perera, and et al. LKB1 modulates lung cancer differentiation and metastasis Nature 448 2007 807 810
15. K.M. Kennedy, P.M. Scarbrough, A. Ribeiro, R. Richardson, H. Yuan, P. Sonveaux, C.D. Landon, J.T. Chi, S. Pizzo, T. Schroeder, and M.W. Dewhirst Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer PLoS ONE 8 2013 e75154
16. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am. J. Roentgenol. 188 2007 1622 1635
17. E.A. Maher, I. Marin-Valencia, R.M. Bachoo, T. Mashimo, J. Raisanen, K.J. Hatanpaa, A. Jindal, F.M. Jeffrey, C. Choi, C. Madden, and et al. Metabolism of [U-13 C]glucose in human brain tumors in vivo NMR Biomed. 25 2012 1234 1244
18. I. Marin-Valencia, C. Yang, T. Mashimo, S. Cho, H. Baek, X.-L. Yang, K.N. Rajagopalan, M. Maddie, V. Vemireddy, Z. Zhao, and et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo Cell Metab. 15 2012 827 837
19. T. Mashimo, K. Pichumani, V. Vemireddy, K.J. Hatanpaa, D.K. Singh, S. Sirasanagandla, S. Nannepaga, S.G. Piccirillo, Z. Kovacs, C. Foong, and et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases Cell 159 2014 1603 1614
20. M.L. McCleland, A.S. Adler, L. Deming, E. Cosino, L. Lee, E.M. Blackwood, M. Solon, J. Tao, L. Li, D. Shames, and et al. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas Clin. Cancer Res. 19 2013 773 784
21. C.S. Ng, D.L. Raunig, E.F. Jackson, E.A. Ashton, F. Kelcz, K.B. Kim, R. Kurzrock, and T.M. McShane Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses AJR Am. J. Roentgenol. 194 2010 W134 W140
22. T.D. Nguyen-Kim, T. Frauenfelder, K. Strobel, P. Veit-Haibach, and M.W. Huellner Assessment of bronchial and pulmonary blood supply in non-small cell lung cancer subtypes using computed tomography perfusion Invest. Radiol. 50 2015 179 186
23. S. Pavlides, D. Whitaker-Menezes, R. Castello-Cros, N. Flomenberg, A.K. Witkiewicz, P.G. Frank, M.C. Casimiro, C. Wang, P. Fortina, S. Addya, and et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma Cell Cycle 8 2009 3984 4001
24. R. Possemato, K.M. Marks, Y.D. Shaul, M.E. Pacold, D. Kim, K. Birsoy, S. Sethumadhavan, H.K. Woo, H.G. Jang, A.K. Jha, and et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer Nature 476 2011 346 350
25. K.N. Rajagopalan, R.A. Egnatchik, M.A. Calvaruso, A.T. Wasti, M.S. Padanad, L.K. Boroughs, B. Ko, C.T. Hensley, M. Acar, Z. Hu, and et al. Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells Cancer Metab. 3 2015 7
26. K. Sellers, M.P. Fox, M. Bousamra 2nd, S.P. Slone, R.M. Higashi, D.M. Miller, Y. Wang, J. Yan, M.O. Yuneva, R. Deshpande, and et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation J. Clin. Invest. 125 2015 687 698
27. J. Son, C.A. Lyssiotis, H. Ying, X. Wang, S. Hua, M. Ligorio, R.M. Perera, C.R. Ferrone, E. Mullarky, N. Shyh-Chang, and et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway Nature 496 2013 101 105
28. P. Sonveaux, F. Végran, T. Schroeder, M.C. Wergin, J. Verrax, Z.N. Rabbani, C.J. De Saedeleer, K.M. Kennedy, C. Diepart, B.F. Jordan, and et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice J. Clin. Invest. 118 2008 3930 3942
29. A. Terunuma, N. Putluri, P. Mishra, E.A. Mathé, T.H. Dorsey, M. Yi, T.A. Wallace, H.J. Issaq, M. Zhou, J.K. Killian, and et al. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis J. Clin. Invest. 124 2014 398 412
30. M.G. Vander Heiden Targeting cancer metabolism: a therapeutic window opens Nat. Rev. Drug Discov. 10 2011 671 684
31. O. Warburg On respiratory impairment in cancer cells Science 124 1956 269 270
32. T.E. Yankeelov, and J.C. Gore Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples Curr. Med. Imaging Rev. 3 2009 91 107
33. M.O. Yuneva, T.W. Fan, T.D. Allen, R.M. Higashi, D.V. Ferraris, T. Tsukamoto, J.M. Matés, F.J. Alonso, C. Wang, Y. Seo, and et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type Cell Metab. 15 2012 157 170